Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral gene therapy.

P Mancheño-Corvo1, P Martín-Duque

  • 1Dpto. de Biotecnología, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Madrid, Spain.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|December 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2012
Same author

Targeting sodium/iodide symporter gene expression for estrogen-regulated imaging and therapy in breast cancer.

Cancer gene therapy·2008
Same author

Non-invasive genetic imaging for molecular and cell therapies of cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2007
Same author

SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene.

Gene therapy·2007
Same author

Use of suicide genes for cancer gene therapy: study of the different approaches.

Expert opinion on biological therapy·2004
Same author

Transient foamy virus vector production by adenovirus vectors.

Gene therapy·2004
Same journal

The preventable burden of tobacco-attributable cancer incidence in Catalonia (Spain) in 2024: a Bayesian approach.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Concordance between multidisciplinary tumor board decisions and AI-based recommendations in endometrial cancer: impact of discordance direction on clinical outcomes.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

External validation of a nomogram for de novo bone metastasis in breast cancer: a single-center Mexican cohort.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Clinical and pathologic insights into early and late breast cancer relapses: a real-world analysis from the El Álamo IV registry.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Neoadjuvant metformin on clinical and pathological response in non-diabetic patients with non-metastatic breast cancer: an updated systematic review and meta-analysis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
See all related articles

Viral vectors are engineered viruses used in gene therapy to deliver therapeutic genes for cancer treatment. Different viral vectors offer unique advantages and limitations for effective cancer gene therapy strategies.

Area of Science:

  • Oncology
  • Gene Therapy
  • Virology

Background:

  • Cancer is a complex genetic disease driven by mutations in tumor suppressor genes and oncogenes.
  • Preclinical studies indicate that gene transfer vectors, often modified viruses, can halt or reverse cancer growth by delivering therapeutic genes.
  • Viral vectors are engineered for efficient delivery and expression of therapeutic genes, making them crucial for cancer treatment strategies.

Purpose of the Study:

  • To review current and emerging virus-based genetic engineering strategies for cancer gene therapy.
  • To discuss the advantages and limitations of various viral vector systems used in clinical trials.
  • To highlight the potential of viral vectors in delivering therapeutic molecules for cancer treatment.

Main Methods:

Related Experiment Videos

  • Review of existing literature on viral vectors in cancer gene therapy.
  • Analysis of different viral vector systems, including retroviruses, adenoviruses, adeno-associated viruses, herpesviruses, and poxviruses.
  • Discussion of the application of these vectors in laboratory and clinical settings.

    • Main Results:

    • Retroviral vectors enable permanent genomic integration but require cell division.
    • Adenoviral vectors offer broad cell tropism but face in vivo immune elimination challenges.
    • Adeno-associated virus (AAV) infects various cell types but has limited DNA capacity, while herpes simplex virus can carry large DNA payloads but faces cytotoxicity issues.

    Conclusions:

    • Various viral vector systems, including retroviruses, adenoviruses, AAV, herpesviruses, and poxviruses, are utilized in over 70% of global gene therapy trials for cancer.
    • Each viral vector possesses distinct advantages and limitations, dictating its suitability for specific cancer gene therapy applications.
    • Virus-based genetic engineering strategies represent a promising frontier for delivering therapeutic molecules and advancing cancer treatment approaches.